Project Grant NA09NMF4270102

This $788,406 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases, under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a sensitive, direct reading bioaerosol detection platform to quantify airborne pathogens such as SARS-CoV-2. Aerosol Devices Inc. will integrate their gentle condensation-growth capture sampler, which concentrates intact, viable virus particles into a small liquid volume...

This Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) to Kasa Bio, L.L.C., a woman-owned small business, aims to develop a higher-order multiplex digital PCR (dPCR) method for detecting important gene fusions related to chronic myeloid leukemia. The $345,285 award, with a performance period from May 1, 2025 to April 30, 2026, will fund the development of Kasa Bio's proprietary "ZIP-Melt" multiplex...

This $575,356 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to The Trustees of Columbia University's Health Sciences Division on August 8, 2025. The funding supports the development of a rapid, multiplexed RT-PCR diagnostic for detecting hepatitis C virus (HCV) infection directly from whole blood samples. The proposed approach leverages plasmonic-based...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded Baebies, Inc., a $1,600,723 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a rapid, point-of-care diagnostic test to identify viable sexually transmitted infections (STIs). The project aims to create a panel of novel STI viability PCR (V-PCR) assays that can differentiate active infection from resolved, non-viable infections. This solution will utilize digital microfluidic...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award to RT Microdx Inc. provides $274,362 to develop a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to provide laboratory-quality accuracy for at-home use by non-healthcare professionals. Key technical objectives include optimizing the sensitivity of the platform's pH-sensitive polymer detection mechanism and ensuring robust performance at...

This Project Grant award from the U.S. Department of Agriculture's (USDA) National Institute of Food and Agriculture (NIFA) under the Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) Program (CFDA 10.212) provides $649,763 to Varigen Biosciences Corp to develop the AQPATHDX kit. This novel multiplex molecular diagnostic assay enables rapid, on-site detection of the most common catfish and tilapia pathogens in less than 30 minutes. The AQPATHDX kit utilizes...

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Colorado State University a $340,408 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and validate an assay for precision antiretroviral therapy to combat drug resistance in HIV patients. The key products and services to be delivered under this award include: Improving the throughput and capacity of an existing infectivity assay using proviral constructs with an H2B-mRFP...

This $389,782 Cooperative Agreement award from the United States Department of Agriculture's Animal and Plant Health Inspection Service (APHIS), under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), aims to develop highly specific and validated TaqMan assays for the simultaneous detection of two critical shrimp diseases: Hepatopancreatic Microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) and Acute Hepatopancreatic Necrosis Disease (AHPND) caused...

The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training federal grant program (CFDA 93.859), awarded a $200,000 Project Grant to Iowa State University of Science and Technology. The grant is titled "IMPROVING MODERN DIAGNOSTICS: DETECTING AND GENOTYPING OF EVOLVING VIRAL PATHOGENS" and runs from Sep 1, 2025 to Jul 31, 2028. The key products and services to be delivered under this award include: Developing a novel branching process...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...